Manufacturers Life Insurance Company, The C4 Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 41,664 shares of CCCC stock, worth $168,739. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,664

Previous 22,918 81.8%

Holding current value

$168,739

Previous $105,000 125.71%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$4.43 - $7.38 $83,044 - $138,345	18,746 Added 81.8%	41,664 $237,000
Q2 2024 Aug 14, 2024	SELL	$4.05 - $8.1 $199,665 - $399,330	-49,300 Reduced 68.27%	22,918 $105,000
Q1 2024 May 14, 2024	BUY	$5.3 - $11.0 $243,211 - $504,779	45,889 Added 174.29%	72,218 $590,000
Q4 2023 Feb 13, 2024	BUY	$1.18 - $6.03 $31,068 - $158,763	26,329 New	26,329 $148,000
Q2 2023 Aug 11, 2023	SELL	$2.75 - $3.77 $45,529 - $62,416	-16,556 Reduced 20.25%	65,195 $179,000
Q4 2022 Aug 11, 2023	SELL	$5.42 - $10.24 $195 - $368	-36 Reduced 0.04%	81,751 $482,000
Q4 2022 Feb 13, 2023	SELL	$5.42 - $10.24 $195 - $368	-36 Reduced 0.04%	81,751 $482,000
Q3 2022 Aug 11, 2023	SELL	$8.03 - $12.77 $55,423 - $88,138	-6,902 Reduced 7.78%	81,787 $717,000
Q3 2022 Nov 03, 2022	SELL	$8.03 - $12.77 $55,423 - $88,138	-6,902 Reduced 7.78%	81,787 $702,000
Q2 2022 Aug 11, 2023	BUY	$5.06 - $26.46 $18,838 - $98,510	3,723 Added 4.38%	88,689 $668,000
Q2 2022 Aug 15, 2022	BUY	$5.06 - $26.46 $18,838 - $98,510	3,723 Added 4.38%	88,689 $655,000
Q1 2022 Aug 11, 2023	BUY	$19.99 - $33.23 $64,267 - $106,834	3,215 Added 3.93%	84,966 $2.06 Million
Q1 2022 May 20, 2022	BUY	$19.99 - $33.23 $1.3 Million - $2.17 Million	65,224 Added 330.38%	84,966 $2.05 Million
Q4 2021 Feb 16, 2022	BUY	$29.39 - $46.86 $10,345 - $16,494	352 Added 1.82%	19,742 $646,000
Q3 2021 Nov 12, 2021	BUY	$35.91 - $50.5 $11,060 - $15,554	308 Added 1.61%	19,390 $866,000
Q2 2021 Aug 12, 2021	BUY	$30.39 - $42.18 $393,975 - $546,821	12,964 Added 211.9%	19,082 $722,000
Q1 2021 May 03, 2021	SELL	$31.96 - $46.5 $1,981 - $2,883	-62 Reduced 1.0%	6,118 $226,000
Q4 2020 Feb 12, 2021	BUY	$22.8 - $37.05 $140,904 - $228,968	6,180 New	6,180 $205,000

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $198M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The C4 Therapeutics, Inc. Transaction History